Alefacept (anti-CD2) causes a selective reduction in circulating effector memory T cells (Tem) and relative preservation of central memory T cells (Tcm) in psoriasis.
Alefacept (anti-CD2) causes a selective reduction in circulating effector memory T cells (Tem) and relative preservation of central memory T cells (Tcm) in psoriasis.
复制标题
DOI:
10.1186/1479-5876-5-27
复制
发表时间:
2007-06-07
影响因子:
7.4
通讯作者:
Lowes MA
中科院分区:
文献类型:
--
作者:
Chamian F;Lin SL;Lee E;Kikuchi T;Gilleaudeau P;Sullivan-Whalen M;Cardinale I;Khatcherian A;Novitskaya I;Wittkowski KM;Krueger JG;Lowes MA
Alefacept (anti-CD2) biological therapy selectively targets effector memory T cells (Tem) in psoriasis vulgaris, a model Type 1 autoimmune disease. Circulating leukocytes were phenotyped in patients receiving alefacept for moderate to severe psoriasis. In all patients, this treatment caused a preferential decrease in effector memory T cells (CCR7- CD45RA-) (mean 63% reduction) for both CD4+ and CD8+ Tem, while central memory T cells (Tcm) (CCR7+CD45RA-) were less affected, and naïve T cells (CCR7+CD45RA+) were relatively spared. Circulating CD8+ effector T cells and Type 1 T cells (IFN-γ-producing) were also significantly reduced. Alefacept causes a selective reduction in circulating effector memory T cells (Tem) and relative preservation of central memory T cells (Tcm) in psoriasis.
登录
查看更多内容
影响因子:
4.4
作者:
Haider, Asifa S.;Lowes, Michelle A.;Krueger, James G.
通讯作者:
Krueger, James G.
DOI:
10.1016/s0190-9622(03)01836-x
发表时间:
2003-11-01
影响因子:
13.8
作者:
Gottlieb, AB;Casale, TB;Gordon, KB
通讯作者:
Gordon, KB
影响因子:
64.8
作者:
Sallusto, F;Lenig, D;Lanzavecchia, A
通讯作者:
Lanzavecchia, A
DOI:
10.1073/pnas.0409569102
发表时间:
2005-02-08
影响因子:
11.1
作者:
Chamian, F;Lowes, MA;Krueger, JG
通讯作者:
Krueger, JG
DOI:
10.1084/jem.186.9.1407
发表时间:
1997-11-03
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Hamann D;Baars PA;Rep MH;Hooibrink B;Kerkhof-Garde SR;Klein MR;van Lier RA
通讯作者:
van Lier RA